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ABSTRACT
Serine integrases are emerging as core tools in syn-
thetic biology and have applications in biotechnol-
ogy and genome engineering. We have designed a
split-intein serine integrase-based system with po-
tential for regulation of site-specific recombination
events at the protein level in vivo. The C31 inte-
grase was split into two extein domains, and in-
tein sequences (Npu DnaEN and Ssp DnaEC) were
attached to the two termini to be fused. Expres-
sion of these two components followed by post-
translational protein trans-splicing in Escherichia
coli generated a fully functional C31 integrase. We
showed that protein splicing is necessary for recom-
bination activity; deletion of intein domains or mu-
tation of key intein residues inactivated recombina-
tion. We used an invertible promoter reporter system
to demonstrate a potential application of the split
intein-regulated site-specific recombination system
in building reversible genetic switches. We used the
same split inteins to control the reconstitution of a
split Integrase-Recombination Directionality Factor
fusion (Integrase-RDF) that efficiently catalysed the
reverse attR x attL recombination. This demonstrates
the potential for split-intein regulation of the forward
and reverse reactions using the integrase and the
integrase-RDF fusion, respectively. The split-intein
integrase is a potentially versatile, regulatable com-
ponent for building synthetic genetic circuits and de-
vices.
INTRODUCTION
It has recently become possible to create computational and
memory systems in cells (1–3) allowing us to foresee many
new ways to enhance the applications of living organisms
(4,5). Engineered cells could act as powerful biosensors with
applications in health, environmental and industrial pro-
cesses. As well as sensing components, it is necessary to pro-
cess the received information and express it as outputs in the
form of specific biological responses (3,6). However, the ge-
netic switches and logic gates that have been constructed to
date are based on a limited repertoire of biological compo-
nent types (7), and there is a need for new systems that can
be used to implement more elaborate and robust devices.
DNA site-specific recombination has been much ex-
ploited for rapid DNA assembly, and to build genetic
switches and memory devices (4,8–10). In a typical mod-
ule, two recombination sites flank a promoter sequence. Ex-
pression of the recombinase promotes inversion of the ori-
entation of the promoter sequence, thus switching between
expression of two genes which are divergently transcribed
from the module (Figure 1A). One group of site-specific
recombinases known as the serine integrases is especially
suited for the construction of switching devices, particularly
because these enzymes promote very efficient and highly di-
rectional recombination (11). For such modules to be use-
ful, fully integrated components of the cell, activity of the
recombinase must be tightly regulated, so that switching oc-
curs only when other cellular conditions are fulfilled. Here
we demonstrate a powerful new approach to regulation of
serine integrase activity, in which the enzyme itself is as-
sembled by intein-mediated fusion of two precursor com-
ponents.
Inteins are naturally occurring autocatalytic systems that
catalyse protein splicing reactions to generate active pro-
teins from precursor polypeptides (12). Synthetic ‘split in-
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Figure 1. Building blocks for split intein-mediated trans-splicing of C31
integrase. (A) Serine integrase catalysed inversion of the orientation of a
promoter sequence functions as a toggle switch for the expression of two
genes. Integrase catalysed recombination between attP and attB sites (ar-
ranged in inverted orientation) results in switching the direction of the pro-
moter, and hence changes the gene expression status of the module. Re-
combination of attR and attL sites by integrase and the RDF, restores the
module to its original state. (B) Split-intein catalysed protein trans-splicing.
Non-covalent association of the N-terminal intein (IN) and the C-terminal
intein (IC) is followed by a trans-splicing reaction that covalently joins the
N-terminal extein (EN) and C-terminal extein (EC). (C) Intein-mediated
protein trans-splicing involves specific chemical steps requiring a catalytic
nucleophile. In this example, cysteine residues are required to mediate the
reactions.
teins’ have been developed to carry out protein splicing in
trans, covalently joining two proteins together for a wide
range of biotechnological applications (13,14) (Figure 1B).
For example, Schaerli et al. (15) split T7 polymerase into
two parts and fused each part to split-intein sequences so
that the two parts were covalently joined together by trans-
splicing. Expression of each of the two individual parts was
placed under the control of an inducible promoter to allow
conditional expression of polymerase activity.
A key requirement for the construction of split-intein sys-
tems is the need to introduce an intein nucleophilic residue
(typically Cys, Ser or Thr; Figure 1C) by mutation of the
sequence of the target protein adjacent to the junction be-
tween the two ‘exteins’. Such changes can potentially lead
to reduction or loss of enzyme activity. However, inteins
have been engineered that tolerate variations of these flank-
ing residues, therebyminimizing the number of changes that
need to be made in the target protein (16,17).
Conditional site-specific recombinase activation by as-
sembly of split protein fragments has been achieved; for ex-
ample, for the popularly used tyrosine recombinaseCre (18–
22). Wang et al. (22) used a Cre split-intein system to recon-
stitute functional recombinase in transgenic mice. However,
there are no reports to date of analogous systems using split
serine integrases. The transposase TnpX (distantly related
to the serine integrases) was split into two parts and some
DNA-binding activity was reconstituted when both parts
were present, but no recombination (transposition) activity
was observed (23).
With the increasing importance of serine integrases as
tools in synthetic biology, methods for signal-induced post-
translational regulation of integrase activity are becoming
very desirable. Here, we report post-translational activation
of site-specific recombination by reconstitution of func-
tional C31 integrase using split intein-catalysed reactions.
MATERIALS AND METHODS
Plasmids and DNA
The codon-optimized C31 integrase sequence was derived
from pFM141 (24). Codon-optimized sequences of NpuN,
a 102-amino acid residue split intein from Nostoc puncti-
forme DnaE and SspC, a 36-amino acid residue split in-
tein from Synechocystis sp. DnaE, were from GeneArt (In-
vitrogen). Plasmids for constitutive expression of the N-
terminal extein-intein fusion protein (Integrase-ExtN-IN) in
Escherichia coli (Figure 2) were made by inserting protein-
coding DNA sequences between NdeI and Acc65I sites in
pMS140, a low-level expression vector with a pMB1 origin
of replication (24). Plasmids for constitutive expression of
the C-terminal intein–extein fusion protein (IC-Integrase-
EC) were made in a similar way by inserting the coding se-
quence between NdeI and Acc65I sites in pEK76, which
has a p15a (pACYC184) origin (24,25). Detailed proper-
ties of the vectors used here for expression of the recom-
binases have been described in detail elsewhere (9,24–27).
Plasmids for tet-inducible expression of the split integrase
components weremade by cloning the protein-codingDNA
sequences between SacI and SalI sites in pTet (28), whilst
those for ara-inducible expression were made by cloning
the protein-coding sequences between SacI and Sal sites in
pBAD (29).
The plasmid substrate for assessing recombination (dele-
tion) by native C31 integrase or trans-spliced C31 in-
tegrase (pC31-delPB) was described in Olorunniji et al.
(24). The sequences of C31 att sites are shown in Sup-
plementary Table S1. The test substrate contains a galK
gene flanked by attP and attB sites arranged in direct repeat
(head-to-tail orientation) resulting in deletion of the galK
gene upon integrase-catalysed recombination. The plasmid
substrate for assessing recombination (inversion) activity
(pC31-invPB) was made by cloning the invertible pro-
moter device shown in Figure 3A in a pSC101 origin plas-
mid with kanamycin resistance selection.
The DNA sequences of all protein constructs and plas-
mid substrates used in this study are shown in Supplemen-
tary Table S2.
Recombination analysis
Assays for integrase-mediated recombination were carried
out in E. coli strain DS941 (24). DS941 was first trans-
formed with the test substrate plasmid (pC31-delPB or
pC31-invPB). The substrate plasmid-containing strains
were then either transformed with an integrase-expressing
plasmid (pFM141), or co-transformed with two plasmids,
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Figure 2. Design of split C31 integrase. (A) Sequence alignment of C31
integrase with related members of the ‘large serine recombinase’ protein
family based on published structures and similar alignments27. Amino
acid sequences in the loop region where C31 integrase is split are high-
lighted with a red box. (B) Structures of the split integrase-intein con-
structs. Changes made to the integrase sequence at the junctions where
the fragments are fused to the split inteins are shown. The functional do-
mains are shown as rectangular boxes: Integrase-EN (blue), Npu DnaEN
(orange), Ssp DnaEC (purple) and Integrase-EC (green). Intein-catalysed
protein trans-splicing generates an active version of the integrase in which
residues at positions 308–312 of wild-type integrase (EGYRIQ) are re-
placed with EYCFN. The trans-spliced integrase is thus one amino acid
shorter than the native integrase. (C) Variants of the split C31 inte-
grase designed to probe the requirements for reconstitution of integrase
activity. (i) Integrase-EN; C31 integrase (1–307). (ii) Integrase-EN-IN;
Integrase-EN (residues 1–307) fused to the 102-amino acid residue Npu
DnaEN (IN) using the two-residueEYand theN-terminal Cys residue from
Npu DnaEN. (iii) Integrase-EN-IN*; C31 integrase (1–307) fused to Npu
DnaEN as described in (i) but with the EY residue at the splice site changed
to GA to inactivate splicing activity. (iv) Integrase-EC; C31 integrase C-
extein (residues 314–605). (v) IC-Integrase-EC; C31 integrase C-extein
(residues 314–605) fused directly to the SspDnaEC (IC). SspDnaEC nucle-
ophilic cysteine residue and the flanking residues required for splicing are
highlighted (CFN). (vi) IC*-Integrase-EC; C31 integrase C-extein fused
to SspDnaEC as described in (i) but with the CFN residue at the splice site
changed to ASA to inactivate splicing activity.
each expressing part of the split integrase. The transfor-
mants were grown on selective MacConkey-galactose indi-
cator plates (MacConkey agar base (Difco) supplemented
with 1% galactose); kanamycin (50 g/ml) was included
Figure 3. In vivo recombination activity of reconstituted split-intein C31
integrase. (A) In vivo recombination assay using a deletion substrate
(pC31-delPB) carrying the galK gene (24). The recombination product
circle carrying the galKDNA has no origin of replication, and is lost dur-
ing subsequent cell divisions. Inability of the cells to metabolize galactose
leads to a change in colony colour on MacConkey galactose medium.
(B) Constitutive expression of precursor polypeptides. The open read-
ing frame of Integrase-EN-IN was expressed from a pACYC184-based
vector, and IC-Integrase-EC was expressed from a pBR322-based vec-
tor (24). Expression of the two polypeptides followed by intein-catalysed
protein trans-splicing reconstitutes C31.Int . (C) Assay of recombi-
nation activities (galK colour assay) of integrase constructs on attP ×
attB deletion substrates (pC31-delPB). In these assays, cells contain-
ing the substrate plasmid (pC31-delPB) were transformed with the ex-
pression vectors indicated and grown for 20 h in selection media. For
analysis of in vivo recombination products, plasmid DNA was recovered
from cells (24) and separated by means of 1.2% agarose gel electrophore-
sis. (1) Substrate only (blank control); (2) FEM141: C31 Integrase; (3)
FEM136: Integrase-EN-IN; (4) FEM137: IC-Integrase-EC; (5) FEM155
(Integrase-EN) and FEM157 (Integrase-EC); (6) FEM136 (Integrase-EN-
IN) and FEM137 (IC-Integrase-EC); (7) FEM136 (Integrase-EN-IN) and
FEM162 (IC*-Integrase-EC); (8) FEM137 (IC-Integrase-EC) and FEM161
(Integrase-EN-IN*).
to select for the substrate plasmid and the recombina-
tion product, whilst ampicillin (50 g/ml) and/or chloram-
phenicol (25 g/ml) were included to select for the inte-
grase expression plasmids. Integrase-mediated deletion of
the galK gene results in pale-coloured (galK−) colonies on
the indicator plates, whereas red (galK+) colonies suggest
lack of recombination. In some cases, colonies inwhich low-
level recombination has occurred maintain a red colour.
To determine the extent of recombination more accurately,
plasmid DNA recovered from the cells was examined. L-
broth (1 ml) was added to the surface of each plate and the
cells were suspended using a plate spreader. An aliquot of
this suspension was used to inoculate L-broth (1 in 1000
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dilution), and the culture was incubated overnight at 37◦C
with kanamycin selection for the substrate and recombi-
nant plasmids. Plasmid DNA was prepared using a Qia-
gen miniprep kit, and analysed by 1.2% agarose gel elec-
trophoresis.
Inducible expression of integrase-intein fusions for trans-
splicing
In vivo expression of the integrase-intein fusion proteins un-
der the control of arabinose and tet inducible promoters
was carried out in strain DS941/Z1 (30), which consitu-
tively expresses TetR, required for regulation of the pTet
promoter. The DS941/Z1 strain was made competent by
a standard calcium chloride method (31). The cells were
transformed with the plasmid substrate pC31-invPB, then
cultured for 90 min and selected on L-agar plates contain-
ing kanamycin (50 g/ml). A single colony was picked and
grown in kanamycin-containing L-broth (5 ml) to make a
stationary phase overnight culture. An aliquot of the sta-
tionary phase culture was then diluted into L-broth con-
taining kanamycin and grown to mid-log phase. These cells
were made ‘chemically competent’ (as above) and trans-
formed with the two vectors containing the coding se-
quences of the intein-integrase fragments. The plasmid vec-
tor pFEM148 (ampicillin selection) expresses Integrase-EN-
IN under the control of the pTet promoter. The second plas-
mid pFEM149 (chloramphenicol selection) expresses IC-
Integrase-EC under the control of the pBAD promoter.
The transformant cells were cultured for 90 min, and se-
lected on L-agar plates containing kanamycin (50 g/ml),
ampicillin (100 g/ml) and chloramphenicol (25 g/ml).
To carry out the recombination assays, a culture from a sin-
gle colony was grown overnight in L-broth in the presence
of the three antibiotics, to stationary phase. The culture was
diluted further (1:100) and grown to mid-log phase (about
90 min), after which expression of the split-intein-integrase
fragments was induced by the addition of anhydrotetracy-
cline, aTc (0.1 g/ml), arabinose, Ara (0.2% w/v) or both.
Glucose was added to 0.4% concentration to the cultures
where it is required to turn off expression of the arabinose
promoter. The induced cultures were grown for 24 h at 37◦C,
after which the cultures were left at room temperature for 8
h. Next, aliquots of each culture (50 l) were diluted with
950 l phage buffer (10 mMTris, pH 7.5, 10 mMMgCl2, 68
mMNaCl), andGFP expression wasmeasured bymeans of
fluorescence.
Fluorescence measurements
Fluorescence measurements were carried out on a Typhoon
FLA 9500 fluorimager (GEHealthcare). Aliquots of the di-
luted cultures (200l) were added to a 96-well plate, and the
fluorescence of the expressed proteins was measured (GFP:
excitation, 485 nm; emission, 520 nm and RFP: excitation,
532 nm; emission, 575 nm). To determine cell density for
each sample, 50 l aliquots were diluted to 1000 l and the
spectrophotometric absorbance was read at 600 nm. The
GFP-independent background signals of the cells were de-
termined bymeasuring the fluorescence ofDS941/Z1 strain
(containing the test substrate but without the split-intein-
integrase expression vectors). The background fluorescence
was subtracted from the values measured for samples in the
different treatment groups, after normalization using the
cell density measurements.
Flow cytometry
Flow cytometry was used to measure single-cell fluores-
cence on a BD Accuri C6 instrument. Cells were washed in
phosphate buffered saline and diluted to∼106 cells/ml. For
each sample, GFP (Ex 488 nm; Em 533/30 nm) and RFP
(Ex 488 nm; Em 585/40 nm) fluorescence was recorded.
The forward scatter threshold was lowered to 10 000 to en-
sure acquisition of bacteria, and gating was performed to
tightly select the dense population of bacteria depicted on
a log scale plot of forward versus side scatter. Samples were
acquired at a slow flow rate of 14 l/min. Data were anal-
ysed using FlowJo™ software (Version 10.6.1).
RESULTS AND DISCUSSION
Design of split-intein serine integrase
We designed our split-intein system for conditional expres-
sion of C31 integrase, a prototype serine integrase, based
on previously reported systems (15). Since the naturalDnaE
split inteins used in this work require an invariant active
site cysteine to remain in the spliced product protein (32–
34), their use for split integrase reconstitution depends upon
the identification of a short region of the protein sequence
where insertion of a cysteine does not disrupt activity. In
addition, for trans-splicing to be essential, the two extein
components of the spliced integrasemust not associate non-
covalently to reconstitute a functional enzyme. We started
by analysing the domain structure of serine integrases to
determine where to split the protein, since a functional split
intein could require introduction of mutations that would
remain in the spliced protein product, if suitably placed nat-
ural Cys, Ser or Thr residues were unavailable. Based on se-
quence alignments of serine integrases (Figure 2A) and pub-
lished crystal structures (35), we split C31 integrase at the
non-conserved region of the recombinase domain between
the 9 and I domains; this region includes a 10–12 residue
loop which is absent in some related serine integrases (36)
(Figure 2A). We therefore predicted that introduction of
the required intein nucleophilic residue and any flanking
residues would not have a deleterious effect on integrase ac-
tivity. Furthermore, Lucet et al. (23) found that when the
related large serine recombinase TnpX (from Clostridium
perfringens) was split between the 9 and I domains, the
two fragments complemented each other to restore DNA
binding (but not recombination) activity.
We then attached twowell-characterised split-intein com-
ponents to the C31 integrase sequences; Npu DnaEN, IN
(102 amino acids) from Nostoc punctiformeDnaE, and Ssp
DnaEC, IC (36 amino acids) from Synechocystis sp. DnaE.
The Npu DnaEN variant contains a L22S change and the
SspDnaEC variant has a P21Rmutation (32). This pair was
chosen based on previous reports that the mutations confer
high trans-splicing activity at 37◦C in E. coli and tolerance
to changes in amino acid sequence at the splicing junctions
(15,32,37).NpuDnaEN (IN) was fused to the C-terminus of
the N-terminal moiety of C31 Integrase (Integrase-EN),
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and Ssp DnaEC (IC) was fused to the N-terminus of the C-
terminal moiety of C31 Integrase (Integrase-EC) (Figure
2B). Also, residues 308–310 of Integrase- EN were changed
from EGY to EY, since these sequences exist naturally at
the extein–intein junction of Npu DnaEN, and Integrase-
EN residues 311–313 were changed from RIQ to CFN, se-
quences found at the intein-extein junction of Ssp DnaEC
(32,37). It is known that these flanking residues are in-
volved in enhancing the splicing efficiencies of this pair of
split inteins (33,37). In the reconstituted trans-spliced inte-
grase (C31.Int ), the natural 6-residue sequence at posi-
tions 308 to 313, EGYRIQ, is replaced with the 5-residue
sequence EYCFN. We made these changes to maximize the
efficiency of the splicing reaction in order to optimize ac-
tivity in E. coli. Hence the reconstituted trans-spliced inte-
grase, C31.Int is one amino acid residue shorter than the
wild-type C31 integrase. Since these changes are in a non-
conserved region (see above), we predicted that they would
not substantially affect recombination activity.
Intein-mediated reconstitution of functional C31 integrase
To assay in vivo recombination activity of our split-intein
C31 integrase, we used a well-characterized colour-based
galk assay (Figure 3A; 26,27,38). The attP and attB re-
combination sites (Supplementary Table S1) on the sub-
strate plasmid pC31-delPB are in a direct repeat orienta-
tion, so that recombination between them causes deletion
of the galK gene. Pale-coloured (galK−) colonies on the in-
dicator plates indicate recombination proficiency, whereas
red (galK+) colonies indicate incomplete or zero recombi-
nation. The coding sequences for Integrase-EN-IN and IC-
Integrase-EC (and also appropriate control proteins; see
Figure 2C) were cloned into separate low-level expres-
sion vectors (24), as illustrated in Figure 3B. An E. coli
strain containing the test substrate was transformed with
these plasmids, and recombination activity was assessed by
colony colour and by gel electrophoresis analysis of plasmid
DNA recovered from the cells (Figure 3C).
Neither Integrase-EN-IN (Figure 3C, lane 3) nor IC-
Integrase-EC (Figure 3C, lane 4) on their own were able
to catalyse attP x attB recombination. Furthermore, co-
expression of the N-extein (Integrase-EN) and C-extein
(Integrase-EC) components of the integrase (lane 5) gave
no recombination. This important control shows that the
intein-less precursor proteins Integrase-EN and Integrase-
EC do not complement each other by non-covalent asso-
ciation to give recombination activity. This contrasts with
reported split tyrosine recombinases, the components of
which associate to reconstitute recombination activity with-
out protein splicing (18–20). When the intein-tagged inte-
grase exteins Integrase-EN-IN and IC-Integrase-EC were co-
expressed, reconstitution of integrase recombination activ-
ity was observed (lane 6). The DNA analysis shown in the
lower panel of Figure 3c (lanes 1–6) suggests that recombi-
nation by the trans-spliced integrase (C31.Int ) has pro-
ceeded to over 80%.
Our results show that the changes from the wild-type in-
tegrase sequence that had to be introduced at the splice
site are compatible with recombination activity. As many
other serine integrases have similarly non-conserved, vari-
able lengths of amino acid sequence in the region of the pro-
tein between 9 and I (Figure 2A), we predict that these
enzymes could also be engineered to create active split-
intein systems.
Trans-splicing is required for integrase recombination activity
The results shown in Figure 3C show that the Npu DnaE
and Ssp DnaE intein moieties are required for reconstitu-
tion of recombination activity, but these experiments do
not unambiguously establish the requirement for trans-
splicing. Some split inteins are known to associate tightly
via non-covalent interactions (39), and this can lead to re-
constitution of the split protein activity, without splicing
(40). To test whether this applies in our split integrase sys-
tem, we mutated the nucleophilic cysteine residue and rate-
enhancing flanking residues at the active sites of the two in-
tein moieties (29) to render them catalytically inactive. We
changed the junction residues ‘EY’ in the Integrase-EN moi-
ety to ‘GA’ and the Cys residue in the Npu DnaEN moi-
ety of Integrase-EN-IN to ‘A’ to give the mutated version
Integrase-EN-IN* (Figure 2c). Similarly, the residues ‘CFN’
in the Ssp DnaEC moiety of IC-Integrase-EC were changed
to ‘ASA’, to derive the mutated version IC*-Integrase-EC
(Figure 2C). No recombination activity was observed when
active Integrase-EN-IN was co-expressed with inactive IC*-
Integrase-EC (Figure 3C, lane 7), nor when active IC-
Integrase-EC was co-expressed with inactive Integrase-EN-
IN* (Figure 3C, lane 8), showing that reconstitution of re-
combination activity requires the catalytic activities of both
split intein fragments. In this aspect, serine integrases differ
from integrases of the tyrosine recombinase family where
non-covalent association is sufficient to allow reconstitu-
tion of activity from split protein fragments (18–20).
The attP x attB in vivo deletion reactions were slower
in cultures where recombination required post-translational
trans-splicing to reconstitute functional integrase, when
compared to recombination by native integrase (see Sup-
plementary Figure S1). It is therefore likely that the rate
of trans-splicing between Npu DnaEN and Ssp DnaEC in
our cell cultures is significantly slower than the fast splic-
ing reaction rate observed in vitro for these intein pairs (37).
The reduced rate might be due to limiting amounts of the
two precursor polypeptides expressed in the cells. It is pos-
sible that this delay is caused by the different rates of ex-
pression of the integrase fragments from the two different
expression vectors used in this study, rather than the actual
trans-splicing reaction in vivo.
Split intein-regulated integrase-catalysed inversion system
To demonstrate the potential application of our split in-
teinC31 integrase in conditional expression of recombina-
tion activity, we designed an invertible genetic system based
on an inversion substrate plasmid, pC31-invPB. Recom-
bination between attP and attB sites in pC31-invPB in-
verts the orientation of a constitutive promoter sequence
(Biobrick J23104), thereby switching expression from RFP
to GFP (Figure 4A). The E. coli strain DS941/Z1/pC31-
invPB was co-transformed with two vectors, each express-
ing one of the two split-intein integrase fragments. Expres-
sion of Integrase-EN-IN was placed under the control of
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Figure 4. Controlling the function of an invertible promoter system using
split intein-regulatedC31 integrase activity. (A) Design of a recombinase-
operated switch using an invertible promoter reporter system. The consti-
tutive promoter sequence (cyan rectangle; Biobrick J23104) is flanked by
C31 integrase attP and attB sites (grey arrows) that are arranged in in-
verted orientation. In its default state, the promoter constitutively drives
the expression of a red fluorescent protein (rfp) gene (pink arrow). The
T1 terminator sequence (red squares) located immediately upstream of the
promoter prevents transcriptional read-through to the green fluorescent
protein (gfp) gene (green arrow). Upon integrase-catalysed site-specific re-
combination, the orientation of the promoter is reversed to allow the ex-
pression of GFP and block RFP production. A Biobrick ribosomal bind-
ing site, RBS, (RBS B0034, blue rectangles), is positioned 5′ of the rfp and
gfp genes to drive optimal translation of the synthesizedmRNAs. (B) Con-
ditional expression of C31 integrase fragments and split intein-mediated
reconstitution of activity. The two split-intein integrase fragments are ex-
pressed from two inducible promoter vectors. Arabinose (ara) induces ex-
pression of Integrase-EN-IN under the control of the pBAD promoter
(pFEM149), whilst anhydrotetracycline (aTc) induces expression of IC-
Integrase-EC under the control of the pTet promoter (pFEM148). Post-
translational trans-splicing of the split-intein integrase fragments generates
the functional reconstituted integrase (C31.Int ). Catalysis of attP x attB
the PBAD promoter, and expression of IC-Integrase-EC was
placed under the control of the Ptet promoter (Figure 4B).
Co-expression of the split-intein fragments (and thus re-
combination) is dependent on the presence of both of the
inducers arabinose and anhydrotetracycline (aTc) (Figure
4C). No recombination (GFP expression) was observed un-
less both split-intein components were expressed (when aTc
and arabinose were added to the growth medium; column
IV.
The split-intein regulated serine integrase can be de-
ployed as an effective tool for transient inversion of genetic
regulatory modules (Figure 4). The ability to reconstitute
integrase activity from inactive protein fragments using split
inteins could allow faster control of site-specific recombi-
nation by specific activation of intein splicing. This could
be achieved by means of light-sensitive protein domains
that regulate intein splicing (39,40) or small molecule lig-
ands that act directly on the split inteins (41) to control the
protein-protein association step that precedes protein trans-
splicing. Fast, accurate switching on of enzyme activity in
vivo could be achieved if methods for efficient conditional
activation of protein trans-splicing were available (42). An
engineered photo-activatable gp41-1 split intein system was
recently shown to work in bacterial cells (43), demonstrat-
ing the feasibility of this approach. Others have demon-
strated the use of pH changes (44) and temperature (45) as
tools for regulating intein functions in vitro. In our system,
conditional splicing would enable fast activation of recom-
bination by reconstituting integrase from the precursors
which are already present. Further development of these
technologies can enhance capacity for building orthogonal
logic gate components for conditional gene expression regu-
lation and genome engineering applications, and add to the
existing tools for programmable cellular functions (46,47).
Intein-mediated assembly of integrase-RDF fusion recombi-
nase and catalysis of attR x attL recombination
We recently showed that recombination between attR x
attL sites can be catalysed efficiently by artificial proteins
in which the recombination directionality factor (RDF) is
fused to the integrase using a short peptide linker. The
fusion recombinase C31.integrase-gp3 catalysed attR x
attL recombination efficiently (24) (Figure 5A). This system
allows more predictable regulation of integrase-catalysed
conversion of attP/attB to attR/attL and vice versa, with
potential applications in building genetic switches and
recombinase-based counters.
To demonstrate the use of our split-intein regulated sys-
tem in attR x attL recombination, we split C31.integrase-
←−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
inversion by C31.Int results in reversal of the orientation of the pro-
moter. (C) Validation of the split-intein C31 integrase recombinational
AND-gate. Fluorescence measurements indicating the expression of GFP
and RFP in cells induced with aTc and/or ara. Cells were grown at 37◦C
for 24 h in the presence of aTc (0.1 g/ml) and ara (0.2%). Glucose was
added to 0.4% concentration to treatments A and C to turn off expression
of the arabinose promoter. Each bar represents mean and standard devia-
tion of four determinations. Below the bar chart are images of Eppendorf
tubes showing the pellet obtained after centrifugation of 5 ml of bacterial
culture.
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Figure 5. Intein-mediated assembly of C31 integrase-RDF fusion re-
combinase and catalysis of attR x attL recombination. (A) Catalysis of
attR x attL recombination by integrase + RDF, or integrase-RDF fu-
sion protein (see text for details). The RDF for C31 integrase is gp3.
(B) Split-intein catalysed assembly of integrase-RDF fusion recombinase.
Non-covalent association of Integrase-EN-IN and IC-Integrase-EC-gp3 via
the intein domains (IN and IC) is followed by a trans-splicing reaction
that gives the fusion recombinase C31.Int -gp3. (C) Assay of recom-
bination activities (galK colour assay) of integrase constructs on attR ×
attL deletion substrate (pC31-delRL). The test substrate is identical to
pC31-delPB (Figure 3A), except that the attP and attB sites are replaced
by attR and attL respectively. (D) The in vivo recombination assay and
analysis are as described in Figure 4C. (1) Substrate only (blank control);
(2) FEM141: C31.Integrase; (3) FEM33: C31.Integrase-gp3 fusion; (4)
FEM136 (Integrase-EN-IN) and FEM137 (IC-Integrase-EC); (5) FEM136
(Integrase-EN-IN) and FEM188 (IC-Integrase-EC-gp3).
gp3 between the 9 and I domains of the integrase (Fig-
ure 5B), at the same position as described above for C31
integrase itself. To test for recombination activity, we used
a test substrate (pC31-delRL) similar to the attP x attB
substrate (pC31-delPB) but with the attP and attB sites re-
placed by attR and attL, respectively (Supplementary Table
S1). The sites are arranged in the head-to-tail orientation
such that deletion of the galK gene leads to a reaction prod-
uct that is smaller in size than the starting substrate (Figure
5C). As expected, neither integrase (Figure 5D, lane 2) nor
co-expression of the Integrase-EN-IN and IC-Integrase-EC
(lane 4) were able to catalyse attR x attL recombination.
In contrast, co-expression of the intein-tagged integrase
N-extein (Integrase-EN-IN) and C-extein-gp3 (IC-Integrase-
EC-gp3) results in efficient attR x attL recombination (lane
5). The extent of recombination by the trans-spliced fusion
recombinase (C31.Int -gp3) was lower than that catalysed
by native C31.integrase-gp3 (lane 3), in line with our ob-
servations for wild-type integrase and its trans-spliced ana-
logue (see above).
Time courses of recombination by wild-type and trans-spliced
integrase
To characterize further the effects of the EYCFNmutations
introduced into the reconstituted integrase (C31.Int ) af-
ter trans-splicing, we carried out a time course comparison
of recombination catalysed by reconstituted and wild-type
integrase. To do this, we made a plasmid expressing the ex-
pected product of trans-splicing, with the EYRIQ sequence
in wild-type C31 integrase replaced with EYCFN. We re-
fer to this construct as C31.Int. Recombination activity
was measured using the invertible promoter reporter sys-
tem (see Figure 4). The extent of recombination was mon-
itored by measuring the progress of switching from RFP
to GFP expression, using single-cell flow cytometry (Fig-
ure 6A).Escherichia coliDS941 cells containing the pC31-
invPB substrate were transformed with appropriate vec-
tor plasmids expressing wild-typeC31 integrase,C31.Int
(Figure 6B); full length C31 integrase with the EYCFN
mutations, C31.Int (Figure 6C); and reconstituted trans-
spliced C31 integrase, C31.Int (Figure 6D). Cells were
cultured with appropriate antibiotic selection and sampled
at 8, 9, 10, 10.5, 11, 11.5, 12 and 24 h. The expression of
GFP following recombination by wild-type integrase was
observable early and peaked at about 10.5 h; a slight fur-
ther increase in GFP expression was observed at 24 h (Fig-
ure 6B). The progress of the reaction by the C31 integrase
with the EYCFNmutations,C31.Int, was slightly slower,
showing a steady increase in GFP expression from 9 to 11.5
h and an even higher level of expression after 24 h. The mu-
tations thus caused a slight decrease in integrase activity
(Figure 6C). In contrast, increase in GFP expression was
noticeably slower when protein trans-splicing (C31.Int)
was required to reconstitute the integrase and activate re-
combination activity (Figure 6D). This is consistent with
our interpretation of the lower activity of trans-spliced in-
tegrase in the experiment shown in Figure 3.
CONCLUSION
Serine integrases promote efficient directional DNA site-
specific recombination, and thus have major potential ap-
plications in genome engineering and metabolic pathway
engineering (9,11,48–51). They have also been incorporated
into the design of cellular state machines and biocomput-
ing devices (4,8,11). Here we have demonstrated a novel
method for regulation of serine integrase activity bymaking
activity dependent on post-translational trans-splicing of
two integrase extein components. Our experiments demon-
strate that the split-intein regulated recombination system
can potentially be used to toggle between twoDNA states in
which the forward reaction is catalysed by a serine integrase,
and the reverse reaction by an integrase-RDF fusion. In a
practical application, reconstitution of the integrase and the
integrase-RDF fusion could be mediated by two pairs of
orthogonal split inteins. Several types of split inteins have
been described in the literature (52,53), and further charac-
terization of their properties would make them available as
orthogonal functional parts. Recently, mutations of theNpu
DnaE split intein have been identified that affect the speci-
ficity, reaction rates, and tolerance to changes in the flank-
ing residues (16,17). Use of these intein variants that toler-
ate a wider range of amino acid residues around the splice
site would require fewer changes to the extein sequence of
the target integrase, thereby reducing the potential risk of
introducing deleterious mutations and making it easier to
find suitable split positions.
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Figure 6. Cytometry time course assays of attP x attB recombination. (A) The assays were carried out using the invertible promoter system described
in Figure 4, in which integrase-catalysed inversion switches expression from RFP to GFP. (B) Wild-type C31 integrase. (C) Full length C31 integrase
with ‘EYCFN’ mutations (C31.Int). (D) Trans-spliced C31 integrase formed in situ (C31.Int ). Integrases were expressed from appropriate plasmid
vectors as follows: (B)C31 Integrase, pFEM141; (C) EYCFNC31 Integrase, pFEM204; (D) Splicing precursor proteins Integrase-EN-IN, pFEM136 and
IC-Integrase-EC, pFEM137. The extent of recombination at the indicated time points was monitored by measuring the amount of GFP formed.
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